share_log
Reuters ·  Apr 29 10:10
Annovis Bio Inc: Annovis Plans to Conduct a Pivotal Disease-Modifying Phase III Trial in Biomarker-Positive Early Ad Patients
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment